Lion Street Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,550
| Closed | -$202K | – | 256 |
|
|
2023
Q2 | $202K | Buy |
+2,550
| New | +$202K | 0.07% | 231 |
|
|
2022
Q3 | – | Sell |
-2,521
| Closed | -$201K | – | 133 |
|
|
2022
Q2 | $201K | Buy |
+2,521
| New | +$201K | 0.11% | 149 |
|
|
2022
Q1 | – | Sell |
-2,569
| Closed | -$226K | – | 143 |
|
|
2021
Q4 | $226K | Buy |
+2,569
| New | +$226K | 0.11% | 141 |
|
|
2020
Q2 | – | Sell |
-5
| Closed | – | – | 75 |
|
|
2020
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 429 |
|